Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ratto-Kim

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|March 8, 2011
Generation and Expansion of HIV-1 CD4+ Antigen-Specific T Cell LinesS Ratto-Kim
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 3, 1999
Varicella immunity: persistent serologic non-response to immunizationR K Katial, S Ratto-Kim, K V Sitz, et al.
The Journal of Infectious Diseases|March 9, 1999
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controlsK V Sitz, S Ratto-Kim, A S Hodgkins, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 21, 2005
Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementiaD A Killebrew, D Troelstrup, V Valcour, et al.
Journal of Virology|March 1, 1997
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell functionR A McDonald, D L Mayers, R C Chung, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120C E Hioe, G J Jones, A D Rees, et al.
The Journal of Infectious Diseases|October 23, 1997
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected personsK V Sitz, L D Loomis-Price, S Ratto-Kim, et al.
The Journal of Infectious Diseases|January 7, 1999
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative responseS Ratto-Kim, K V Sitz, R P Garner, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|March 8, 2011
Generation and Expansion of HIV-1 CD4+ Antigen-Specific T Cell LinesS Ratto-Kim
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 3, 1999
Varicella immunity: persistent serologic non-response to immunizationR K Katial, S Ratto-Kim, K V Sitz, et al.
The Journal of Infectious Diseases|March 9, 1999
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controlsK V Sitz, S Ratto-Kim, A S Hodgkins, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 21, 2005
Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementiaD A Killebrew, D Troelstrup, V Valcour, et al.
Journal of Virology|March 1, 1997
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell functionR A McDonald, D L Mayers, R C Chung, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120C E Hioe, G J Jones, A D Rees, et al.
The Journal of Infectious Diseases|October 23, 1997
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected personsK V Sitz, L D Loomis-Price, S Ratto-Kim, et al.
The Journal of Infectious Diseases|January 7, 1999
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative responseS Ratto-Kim, K V Sitz, R P Garner, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
Pageof 2